Abeona Therapeutics Inc.
ABEO
$5.40
-$0.01-0.09%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 211.69% | 215.93% | 208.83% | 42.36% | -17.62% |
| Total Depreciation and Amortization | 22.57% | 13.85% | 6.94% | -1.19% | -9.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1,684.39% | -898.59% | -3,085.33% | -137.63% | -41.69% |
| Change in Net Operating Assets | -22.91% | -1,944.02% | 173.08% | -92.44% | -145.13% |
| Cash from Operations | -36.26% | -53.89% | -56.34% | -50.44% | -51.36% |
| Capital Expenditure | -226.04% | -295.74% | -250.16% | -272.55% | -638.97% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -100.00% | -91.18% | -91.18% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 406.97% | 372.16% | 408.76% | -162.42% | -11,088.66% |
| Cash from Investing | 367.66% | 345.45% | 392.09% | -177.09% | -18,965.38% |
| Total Debt Issued | -- | -100.00% | -100.00% | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -69.55% | -68.17% | -79.43% | 96.34% | 129.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 97.52% | 85.33% | 59.28% | 58.39% | -348.49% |
| Cash from Financing | -74.99% | -73.90% | -82.81% | 36.75% | 181.02% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 516.19% | 509.75% | 357.82% | -112.60% | 3,370.31% |